Job openings at the Campaign Click here
Reality Check on TB diagnostics MSF at the Union Conference
Does the 'August 30 Decision' deliver the medicines we need ? Read more
MSF hosts malnutrition symposium in NY Read more
FDA quality warning to Ranbaxy Read MSF's statement
- © Donald Weber
Reality Check on TB diagnostics MSF is holding a satellite meeting at the Union Conference in Paris to explore our and others' experience of diagnosing TB in the places where we work Read more
- © Sebastien Rich
" More straightjacket than incentive " The so-called August 30th Decision was tacked on to the TRIPS agreement with the intent of expanding access to affordable medicines through the use of compulsory licensing. Five years on, it's still hasn't delivered effectively Read more
- ©MSF
PMTCT: Overcoming the obstacles In June, MSF held an Experts Roundtable in Geneva to discuss the current limitations of prevention of mother-to-child transmission of HIV (PMTCT) programmes in the developing world Find out more
- © Daniel Jaquet
Nutrition Symposium: Food aid and nutrition experts, representatives from donor institutions and aid organisations together with political leaders met in New York at an MSF co-hosted event to work on ways to tackle the scourge of childhood malnutrition Read press release
Read more about the event, co-hosted by MSF and Columbia University
- © Donald Weber
The Cambridge Declaration MSF has become a founder member of a new initiative, bringing together many actors in the field, that aims to drive forward clinical research into better treatment of drug-resistant TB.
Will the AMC be too expensive? In less than a month donors will be signing the deal for the pilot Advanced Market Commitment for the pneumococcal vaccine. Read more
Fighting for better drugs
Dr. Johan van Grievsen, an HIV doctor in Rwanda with MSF until the end of 2007, describes the severe side effects of some antiretrovirals drugs and why patients need access to a better drug - tenofovir - but at an affordable price.
|
Developing drugs for developing countries
MSF authors argue that drug companies need to ensure the needs of patients in developing countries are integrated into drug development plans
Give us the tools we need
From an effective diagnostic test for TB, to drugs that work against Chagas disease and HIV treatments for children and pregnant women - none of these are available to our teams in the field because of the failure of the current system of medical R&D. Read more about the medical challenges we face and some solutions that could deliver the medical tools we need to treat our patients. |
Press releases
Key publications
Field news
06 October 2008
“Access to Maternal-Infant Prevention and to Preventative Treatment Makes a Difference”
06 October 2008
HIV-TB Co-infection: They’re already sitting in our waiting rooms
06 October 2008
